Connect with us

Buyers Speak

In-vitro diagnostics in India – The future ahead

The Indian in-vitro diagnostics (IVDs) market size is estimated at USD 1.71 billion in 2024, and is expected to reach USD 2.34 billion by 2029, growing at a rate of 6.58 percent during the period, 2024 to 2029. Widened research and development for the application of IVDs for better and quick diagnostics increased recently in India. Moreover, a press release published by Clinical Trials Arena (CTA) in September 2021 mentioned that chronic illness among the Indian population increased during the Covid-19 lockdown. Thus, the increased cases of chronic diseases in India during the pandemic phase are anticipated to generate demand for IVDs.

Additionally, increased use of pandemic-required innovations, such as remote collection and digital pathology, is expected to fuel market growth, for instance, expanded digital platform for primary diagnostic workflows and slide scanner that produces excellent image quality of stained histology slides from patient tissue samples while providing ease of use and workflow flexibility for the pathology lab. Thus, such technological advancements and product launches to ease in-vitro diagnostics procedures are anticipated to impact the market significantly.

The major factors driving the growth of the Indian in-vitro diagnostics market are rising awareness and acceptance of personalized medicine and companion diagnostics. The increasing number of cases of chronic diseases, such as cancer, diabetes, and others in the country is the key factor driving the market’s growth. The rising burden of cancer raises the need to detect cancer early for more effective and timely treatment, increasing the demand for in-vitro diagnostics. Similarly, the expected increase in the number of people who have diabetes will increase the demand for conducting in-vitro assays for detecting blood glucose and other related parameters.

Furthermore, emerging technological innovations in healthcare, such as biosensors, lab-on-a-chip, wearable devices, and point-of-care (POC) diagnostics, are increasingly becoming an important part of the healthcare landscape. POC testing helps bring testing closer to the patients and obtain results quickly for the healthcare provider to expedite diagnoses and subsequent treatment. POC testing systems at doctor offices, nursing homes, and community health centers, through lab partners, enable patients to get test results faster at a lower cost. This is likely to increase the adoption of in-vitro diagnostics in India. Moreover, rising company activities in developing in-vitro diagnostic products and increasing product launches in the country contribute to the market’s growth.

Discoveries like genomics and genetic testing will make diagnostic services more personalized to the needs of customers, and technological advancements and investments in a digital platform for in-vitro tests will make the Indian IVD industry more accessible to clinicians and patients globally. The molecular diagnostics segment is expected to witness significant growth in the in-vitro diagnostics market owing to the factors, such as outbreaks of bacterial and viral epidemics, and rapidly evolving technology. Molecular diagnostic devices are used to analyze biological markers in the genome and proteome to detect pathogens or mutations. Based on the technology, molecular diagnostic devices can be segmented into chips and microarrays, mass spectroscopy, next-generation sequencing (NGS), polymerase chain reaction (PCR)-based methods, cytogenetics, and molecular imaging. Based on the above factors, the studied segment is anticipated to grow.

The quality of medical devices is governed by regulatory authorities of the respective countries. The regulations are intended to protect the risks associated with design, manufacture, and packaging of medical devices. India is one of the top twenty markets for medical devices in the world and the fourth-largest market in Asia. The National Medical Device Policy 2015 is framed out by the Government of India to strengthen the medical devices market and decreasing dependence on importing the medical devices. The Indian medical devices sector is about USD 4.9 billion in which 53 percent are IVDs. The in-vitro diagnostic advisory committee (IVDAC) is established by the Government of India to give advice in matters related to IVDs.

However, too stringent regulations and cumbersome reimbursement procedures will likely hamper the market growth over the forecast period.

Copyright © 2024 Medical Buyer

error: Content is protected !!